FNY Investment Advisers LLC Raises Stake in Amedisys, Inc. (NASDAQ:AMED)

FNY Investment Advisers LLC raised its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 6,942.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,000 shares of the health services provider's stock after acquiring an additional 4,929 shares during the quarter. FNY Investment Advisers LLC's holdings in Amedisys were worth $463,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in AMED. Empowered Funds LLC purchased a new position in Amedisys in the fourth quarter worth approximately $318,000. Blue Trust Inc. lifted its stake in Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares during the last quarter. Rhumbline Advisers lifted its stake in Amedisys by 1.6% in the fourth quarter. Rhumbline Advisers now owns 91,298 shares of the health services provider's stock worth $8,289,000 after acquiring an additional 1,412 shares during the last quarter. State of New Jersey Common Pension Fund D lifted its stake in Amedisys by 14.6% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 23,324 shares of the health services provider's stock worth $2,118,000 after acquiring an additional 2,967 shares during the last quarter. Finally, Venturi Wealth Management LLC lifted its stake in Amedisys by 397.4% in the fourth quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after acquiring an additional 779 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company's stock.

Amedisys Stock Performance

Shares of Amedisys stock opened at $97.16 on Monday. The firm has a market capitalization of $3.19 billion, a P/E ratio of 38.56, a P/E/G ratio of 1.78 and a beta of 0.94. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm's 50 day moving average is $94.07 and its two-hundred day moving average is $91.93.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. The business had revenue of $594.78 million for the quarter, compared to analyst estimates of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period last year, the firm posted $1.03 earnings per share. Research analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AMED has been the topic of several recent analyst reports. Stephens reiterated an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a research note on Tuesday, March 4th. Royal Bank of Canada reiterated an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a research note on Wednesday, April 16th. Finally, Wall Street Zen lowered shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $100.75.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys, Inc. (NASDAQ:AMED - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.